Economic impact of new interventional therapies: are we asking the right questions?
- PMID: 15519011
- DOI: 10.1016/j.jacc.2004.08.010
Economic impact of new interventional therapies: are we asking the right questions?
Comment on
-
Economic evaluation of bivalirudin with provisional glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coronary intervention: results from the REPLACE-2 trial.J Am Coll Cardiol. 2004 Nov 2;44(9):1792-800. doi: 10.1016/j.jacc.2004.05.085. J Am Coll Cardiol. 2004. PMID: 15519009 Clinical Trial.
-
Cost-effectiveness of distal embolic protection for patients undergoing percutaneous intervention of saphenous vein bypass grafts: results from the SAFER trial.J Am Coll Cardiol. 2004 Nov 2;44(9):1801-8. doi: 10.1016/j.jacc.2004.05.086. J Am Coll Cardiol. 2004. PMID: 15519010 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
